Early-stage trials of a new drug for advanced prostate cancer have yielded "remarkable" results, according to medical experts.
This innovative treatment, an immunotherapy designed to harness the body's own immune system against cancer, demonstrated its ability to either shrink existing tumours or prevent their further growth.